HF 182: A bill for an act relating to controlled substances, including certain controlled substances schedules and precursor substances reporting requirements, making penalties applicable, and including effective date provisions. - Iowa

Enrolled → Enrolled with Governor's Action · 7 edits · Mar 28, 2025

MODERATE

This bill updates Iowa's controlled substances list by adding numerous new synthetic opioids, designer drugs, and anabolic steroids to the state's prohibited substances schedules. The changes expand law enforcement and regulatory authority to cover emerging drug variants that were not previously controlled, including new fentanyl analogs and research chemicals. These additions aim to close legal loopholes that allowed these substances to be sold or distributed without restriction.

Scope change

The bill significantly expands the scope of controlled substances in Iowa by adding dozens of new chemical compounds to the state's prohibited lists, primarily targeting synthetic opioids and designer drugs that have emerged as public health concerns.

REQUIREMENT

Added 19 new synthetic opioid and designer drug compounds to Section 124.204, including fentanyl analogs like alpha'-Methyl butyryl fentanyl and research chemicals like etodesnitazene.

Added 21 new anabolic steroid compounds to Section 124.208, including brominated and chlorinated derivatives of testosterone and related hormones.

Added Zuranolone to Section 124.210 as a new controlled substance.

Expanded Section 124B.2 to include N-phenylpiperidin-4-amine and its derivatives as controlled substances.

Added new subsection 5 to Section 124B.6 regarding chemical mixtures exempt by federal regulation.

Removed and replaced specific paragraphs in Sections 124.204 and 124.208 to update the controlled substance lists with current drug variants.

TIMELINE

The act takes effect immediately upon enactment, allowing the new controlled substance designations to be enforced right away.

Introduced → Signed Enrolled Bill (PDF) · 7 edits · Mar 28, 2025

MODERATE

This bill expands Iowa's controlled substances list by adding numerous new synthetic opioids, stimulants, and designer drugs to existing schedules. It also updates precursor substance reporting requirements and clarifies penalties for violations. The changes reflect a response to emerging drug threats and align state regulations with federal standards.

Scope change

The bill significantly expands the scope of controlled substances in Iowa by adding dozens of new chemical compounds to existing schedules, particularly focusing on fentanyl analogs and synthetic opioids that were not previously regulated under state law.

SCOPE

Added 15 new fentanyl analogs and related synthetic opioids to Schedule I, including alpha'-Methyl butyryl fentanyl, 2',5'-Dimethoxyfentanyl, and various fluorinated fentanyl variants.

Added 10 new synthetic cathinones and designer stimulants to Schedule I, including ADB-BUTINACA, alpha-PiHP, and 3-MMC.

Added 20 new synthetic cannabinoids and related compounds to Schedule I, including MDMB-4en-PINACA, CUMYL-PEGACLONE, and various nitazene analogs.

Added 20 new anabolic steroids and related compounds to Schedule III, including brominated and chlorinated derivatives of testosterone and other androgenic substances.

REQUIREMENT

Updated precursor substance reporting requirements to include new chemical designations and expanded definitions of controlled substances.

ENFORCEMENT

Maintained existing penalty structure but expanded it to cover the newly added controlled substances with class B, C, and misdemeanor penalties.

TIMELINE

Bill takes effect immediately upon enactment, with no delayed effective date provisions.

Signed Enrolled Bill (PDF) → Enrolled · 5 edits · Mar 28, 2025

MODERATE

This bill adds numerous new synthetic opioids, stimulants, and designer drugs to Iowa's controlled substances schedules. The changes expand the state's ability to regulate emerging psychoactive substances that were not previously covered under existing laws. This update ensures Iowa can enforce penalties against possession and distribution of these new substances.

Scope change

The bill significantly expands the scope of controlled substances by adding 30+ new chemical compounds to Iowa's regulated list, including fentanyl analogs, nitazene derivatives, and synthetic cannabinoids.

SCOPE

Added 10 new fentanyl analogs including alpha-Methyl butyryl fentanyl, 2',5'-Dimethoxyfentanyl, 3-Furanyl fentanyl, Isovaleryl fentanyl, meta-Fluorofentanyl, meta-Fluoroisobutyryl fentanyl, ortho-Fluorofuranyl fentanyl, para-Methoxyfuranyl fentanyl, and para-Methylcyclopropyl fentanyl.

Added 4 new nitazene derivatives including 2-Methyl AP-237, etodesnitazene, etonitazepyne, and protonitazene.

Added 10 new synthetic cannabinoids and related compounds including ADB-BUTINACA, alpha-PiHP, 3-MMC, MDMB-4en-PINACA, 4F-MDMB-BUTICA, ADB-4en-PINACA, CUMYL-PEGACLONE, 5F-EDMB-PICA, MMB-FUBICA, and N-desethyl isotonitazene.

Added 20 new designer steroid compounds including various brominated, chlorinated, and methylated androgen derivatives.

REQUIREMENT

Struck existing paragraphs from controlled substance schedules and replaced them with new comprehensive lists to ensure outdated substances are removed while new ones are added.

A bill for an act relating to controlled substances, including certain controlled substances schedules and precursor substances reporting requirements, making penalties applicable, and including effective date provisions.

What changed between versions

How they voted

Actions timeline

Sponsors